Cost of new Alzheimer's drug could put it out of reach for many in Australia

Headlines on health
23/08/2024 6 min
Cost of new Alzheimer's drug could put it out of reach for many in Australia

Listen "Cost of new Alzheimer's drug could put it out of reach for many in Australia"

Descargar episodio Ver en sitio original

Episode Synopsis

The development of the first drug in 30 years that modifies the disease - and not just the symptoms - of the most common form of dementia has given hope to patients. The drug Lecanemab is now undergoing a regulatory approval process in Australia and other countries in the world, but its exorbitant cost means few will be able to access it.

More episodes of the podcast Headlines on health

'Make memories’: the tragic reality of childhood DIPG and the new research giving families hope 06/12/2025
'Adult’ pressures hit hard as UNICEF warns teens are losing hope 25/11/2025
'Isolation and shame': Australians are avoiding perinatal mental health support, new research reveals 23/11/2025
Chris Minns on hospital funding row: we can't all be wrong 19/11/2025
'It shouldn't be painful to be a woman': Victorian report lays bare health care battle 10/11/2025
'Heartbreaking': Experts argue egg donation rules could change to help Australia's fertility issues 08/11/2025
New concussion guidelines launched to help patients get the right care 04/11/2025
Aged care reforms: Who will pay more under the new system? 01/11/2025
Kidney disease drug added to PBS, helping 65,000 Australians 28/10/2025
Peanut butter loving babies are licking allergies, study suggests 25/10/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA